Loading insider details...
Beta
Latest Form 4 (Jul 9, 2026): Grant/Award of 25,000 CLRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 9, 2026 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 25,000 | n/a |
| Nov 18, 2025 | Lite Strategy, Inc. (LITS) | Grant/Award | 55,000 | n/a |
| Jul 18, 2025 | MEI Pharma, Inc. (MEIP) | Grant/Award | 20,000 | n/a |
| Feb 18, 2025 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 60,000 | n/a |
| Jan 3, 2025 | Cue Biopharma, Inc. (CUE) | Grant/Award | 24,400 | n/a |
| Jun 18, 2024 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 60,000 | n/a |
| Jan 4, 2024 | Cue Biopharma, Inc. (CUE) | Grant/Award | 24,400 | n/a |
| Oct 12, 2023 | MEI Pharma, Inc. (MEIP) | Grant/Award | 10,000 | n/a |
| Jun 28, 2023 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 25,000 | n/a |
| Jan 5, 2023 | Cue Biopharma, Inc. (CUE) | Grant/Award | 10,000 | n/a |